Some clinical studies report on a low CD8 expression found on tumor-infiltrating T lymphocytes in patients with endometrial carcinoma compared to healthy tissue (30), in patients with lung adenocarcinoma (31) but also low CD8 gene expression in cancer patients with non-response to checkpoint inhibition (32). The gene discussed is CD8A; the disease is neoplasm.